Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 9.64% vs -4.43% in Sep 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -224.31% vs 57.78% in Sep 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is -78.19% vs -194.55% in Sep 2025
Interest
QoQ Growth in quarter ended Mar 2026 is -100.00% vs 0.00% in Sep 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Sep 2025
Compare Quarterly Results Of Beijing Hotgen Biotech Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 9.64% vs -4.43% in Sep 2025
YoY Growth in quarter ended Mar 2026 is 24.46% vs -19.72% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -224.31% vs 57.78% in Sep 2025
YoY Growth in quarter ended Mar 2026 is -89.24% vs -1,348.57% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -78.19% vs -194.55% in Sep 2025
YoY Growth in quarter ended Mar 2026 is -35.52% vs -758.76% in Mar 2025
Quarterly - Interest
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Sep 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025






